3SBio Inc. to Present at 30th Annual J.P. Morgan Healthcare Conference SHENYANG, China, Jan. 4, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced Dr. Jing Lou, 3SBio's chief executive officer will present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco on January 11, 2012 at 1:30pm pacific time. Audio webcasts with accompanying slides will be available live and archived at www.3sbio.com under the investor relations section until February 11, 2012. About 3SBio Inc. 3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and MP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX." Please see www.3SBio.com for more information. Investor Contacts Bo Tan Tom Folinsbee Director of Investor Relations 3SBio Inc.